home / stock / adtx / adtx news

ADTX News and Press, ADiTx Therapeutics Inc. From 10/05/21

Stock Information
Company Name: ADiTx Therapeutics Inc.
Stock Symbol: ADTX
Market: NASDAQ
Website: aditxt.com
Menu
ADTX ADTX Quote ADTX Short ADTX News ADTX Articles ADTX Message Board
Get ADTX Alerts

News, Short Squeeze, Breakout and More Instantly...
ADTX - ADTX Stock: The Huge Covid-19 News Lifting Aditxt Today

InvestorPlace - Stock Market News, Stock Advice & Trading Tips Today, one of the big movers in the market is  Aditxt  (NASDAQ: ADTX ). Indeed, ADTX stock has risen approximately 8% at the time of writing on very heavy volume. However, at one point today, shares of this bi...
ADTX - AiPharma Signs Binding Agreement To Sell To Aditxt Inc (Nasdaq: ADTX). AiPharma Is The Rights Holder Of Antiviral Tablet Avigan / Reeqonus / Qifenda That Has Treated Over 1.5M COVID-19 Patients Since The Outbreak.

AiPharma Signs Binding Agreement To Sell To Aditxt Inc (Nasdaq: ADTX). AiPharma Is The Rights Holder Of Antiviral Tablet Avigan / Reeqonus / Qifenda That Has Treated Over 1.5M COVID-19 Patients Since The Outbreak. PATIENTS WITH MILD TO MODERATE SYMPTOMS OF COVID-19 CAN TAKE THE ...

ADTX - Aditxt, Synaptogenix leads healthcare gainers; UpHealth, Unity Biotechnology among major losers

Gainers: Aditxt (NASDAQ:ADTX) +22%, Synaptogenix (NASDAQ:SNPX) +17%, Shineco (NASDAQ:TYHT) +13%, SmileDirectClub (NASDAQ:SDC) +12%, Silverback Therapeutics (NASDAQ:SBTX) +9%. Losers: UpHealth (NYSE:UPH) -34%, Unity Biotechnology (NASDAQ:UBX)&#...

ADTX - Aditxt Signs a Transaction Agreement to Acquire AiPharma, Rights Holder of Antiviral Tablet Avigan/Reeqonus/Qifenda Used in the Treatment of Over 1.5 Million COVID-19 Patients Outside the U.S. and Canada

Phase 3 clinical trial of Avigan/Reeqonus for treatment of COVID-19 completed enrollment of more than 1,200 patients in the U.S., Mexico and Brazil with topline results expected in less than 60 days Aditxt, Inc. (“Aditxt”) (Nasdaq: ADTX), a biotech innovati...
ADTX - Aditxt Appoints Corinne Pankovcin as President and Thomas J. Farley as Chief Financial Officer as Company Prepares for Global Commercialization

Aditxt, Inc. (“Aditxt, or the “Company”). (Nasdaq: ADTX), a biotech innovation company with a mission to improve the health of the immune system, today announced key executive management changes to support its growth plans. Corinne Pankovcin, who has served as C...

ADTX - FRO, TELL and MTNB among pre market gainers

Puhui Wealth Investment (NASDAQ:PHCF) +55%. Red Cat Holdings RCAT +50% after subsidiary receives five-year contract with NASA Paltalk (NASDAQ:PALT) +36%. Vinco Ventures (NASDAQ:BBIG) +16%. VIZIO Holding (NYSE:VZIO) +10%. U.S. Energy (NASDAQ:USEG) +8%. Syndax Pharmaceuticals (NASDAQ:...

ADTX - Aditxt, Inc. and SphereDX Launch AditxtScore(TM) for COVID-19 in Kentucky, Ohio and Indiana to Address Individual Immune Status Uncertainty and Help Evaluate Cadence for Booster Shots

Initial AditxtScore testing found one-third of fully vaccinated assisted living community residents needed booster vaccinations to strengthen individual antibody response Aditxt, Inc. (Nasdaq: ADTX), a biotech innovation company with a mission to improve the health of the im...
ADTX - Aditxt Announces Closing of $11 Million Registered Direct Offering, and Funding of Bridge Loan Satisfying a Key Term of its Letter of Intent for Planned Acquisition of Commercial Stage Pharma Company with Anti-Viral COVID-19 Therapy

Aditxt, Inc. (Nasdaq: ADTX), a biotech innovation company with a mission to improve the health of the immune system, today announced it has closed on a registered direct offering for $11 million announced on August 26, 2021 and funded a bridge loan to its acquisition target, satisfying ...

ADTX - Catalyst watch for next week: OPEC meeting, Autodesk event and semis/IT conference

Welcome to Seeking Alpha's Catalyst Watch - a breakdown of some of next week's actionable events that stand out. Check out Saturday morning's regular Stocks to Watch article for a full list of events planned for the week or the Seeking Alpha earnings calendar for companies due to report. Mond...

ADTX - ZOM, MRAM and DLPN among midday movers

Gainers: Glory Star New Media Group Holdings (NASDAQ:GSMG) +41%. SGOCO (NASDAQ:SGOC) +35%. Ascendis Pharma A/S (NASDAQ:ASND) +22%. Zomedica (NYSE:ZOM) +18%. Dolphin Entertainment (NASDAQ:DLPN) +17%. Jowell Global (NASDAQ:JWEL) +18%. Lordstown Motors (NASDAQ:RIDE) +17%. ABVC BioPharma (OTCQB:A...
Previous 10 Next 10